Press Release
Apmonia Therapeutics strengthens its drug discovery capabilities and extends its collaboration with the Max Mousseron Institute of Biomolecules (IBMM)
This collaboration between the biotechnology company and a leading team in molecular modeling strengthens Apmonia Therapeutics’ ability to identify new therapeutic targets in the extracellular
December 16, 2024
16 h 28 min
